Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

InnoPharmax, Inc. (4172) Financial Statements

InnoPharmax, Inc. Financial Overview

InnoPharmax, Inc.'s market cap is currently NT$1.08B. The company's EPS TTM is NT$-1.84; its P/E ratio is -5.16; InnoPharmax, Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 68.99MNT$ 32.30MNT$ 46.07MNT$ 29.13MNT$ 48.06M
Gross ProfitNT$ 3.51MNT$ 20.76MNT$ 17.46MNT$ -377.00KNT$ 7.41M
Operating IncomeNT$ -171.76MNT$ -95.98MNT$ -64.84MNT$ -93.33MNT$ -74.37M
EBITDANT$ -165.44MNT$ -90.05MNT$ -53.92MNT$ -88.74MNT$ -69.77M
Net IncomeNT$ -184.40MNT$ -99.29MNT$ -70.83MNT$ -103.18MNT$ -92.97M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 154.86MNT$ 294.24MNT$ 152.31MNT$ 104.57MNT$ 187.26M
Total AssetsNT$ 468.98MNT$ 633.06MNT$ 524.20MNT$ 489.31MNT$ 556.16M
Total DebtNT$ 11.07MNT$ 15.39MNT$ 21.50MNT$ 37.55MNT$ 5.57M
Net DebtNT$ -86.21MNT$ -151.34MNT$ -17.86MNT$ -2.97MNT$ -84.93M
Total LiabilitiesNT$ 49.80MNT$ 30.21MNT$ 48.65MNT$ 58.31MNT$ 24.61M
Stockholders' EquityNT$ 419.18MNT$ 602.85MNT$ 475.55MNT$ 431.00MNT$ 531.54M
Cash Flow
Free Cash FlowNT$ -134.72MNT$ -76.81MNT$ -48.97MNT$ -100.20MNT$ -51.48M
Operating Cash FlowNT$ -134.45MNT$ -76.22MNT$ -48.57MNT$ -100.08MNT$ -50.03M
Investing Cash FlowNT$ 69.31MNT$ -15.59MNT$ -50.01MNT$ 31.32MNT$ -36.60M
Financing Cash FlowNT$ -4.32MNT$ 219.18MNT$ 97.41MNT$ 18.77MNT$ -4.26M

Currency in TWD

InnoPharmax, Inc. Earnings and Revenue History

-400M-200M0200M-450 %-300 %-150 %0 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

InnoPharmax, Inc. Liabilities to Assets

0250M500M750M0 %12 %24 %36 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

InnoPharmax, Inc. Cash Flow

-200M-100M0100M200M300M2019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

InnoPharmax, Inc. Forecast EPS vs Actual EPS

Earnings >